Discovery of Genetic Protein that Impacts Hepatitis C Recovery
Hepatitis-C Virus Treatment Affected By Newly Discovered Gene Mutation: NIH
Added by GM on January 7, 2013.
The National Institutes of Health, (NIH), a division of the U.S. Department of Health and Human Services (HHS), announced in a press release dated 1/6/2013 that scientists from the National Cancer Institute (NCI) have discovered a gene mutation that affects the treatment of the Hepatitis C virus.
Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts how people respond to treatment for hepatitis C infection. The results of this study, by investigators at the National Cancer Institute (NCI), part of the NIH, and their collaborators at NIH and other institutions, were published online in Nature Genetics on Jan. 6, 2013.
Continue reading this entire article:
Treatment for Hepatitis C Genotype 2
Gilead’s Hep C Regimens Progressing Forward